Diseases: Page 5

Study: Novel type of inhibitor may prevent microvascular diabetic complications

A new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease, research suggests.

February 15, 2024

Diabetes Insulin Glucose Blood Social

Gold-enhanced nanopore sensors detect ovarian cancer biomarker in urine

By Nick Paul Taylor

Nanopore sensors that use gold nanoparticles to capture certain peptides could enable the detection of ovarian cancer biomarkers in urine samples, according to a paper published in ACS Sensors.

February 14, 2024

Ovarian Cancer2 Social

NHS lacks capacity for Alzheimer’s diagnostics, warn experts

Many thousands of patients in the U.K. could miss out on new treatments for Alzheimer’s disease because its National Health Service (NHS) lacks capacity for diagnostic tests, warn experts.

February 14, 2024

Amyloid Plaque Alzheimer2 Social

Quest Diagnostics seeks to get a jump on PFAS testing in communities

Researchers often use people’s blood PFAS levels as a proxy for exposure to perfluoroalkyl and polyfluoroalkyl substances, the "forever chemicals" found in certain products and the environment.

February 13, 2024

This U.S. Geological Survey (USGS) map shows the number of PFAS detected in tap water samples from select sites across the nation. The findings are based on a USGS study of samples taken between 2016 and 2021 from private and public supplies at 716 locations. The map does not represent the only locations in the U.S. with PFAS. (Source: USGS, public domain.)

CorDx submits EUA application for COVID-19/influenza rapid test

By LabPulse.com staff writers

CorDx has submitted an Emergency Use Authorization (EUA) application for its CorDx TyFast Flu A/B & COVID-19 Multiplex Rapid Test to the U.S. Food and Drug Administration (FDA).

February 10, 2024

Influenza Virus Social

T2 Biosystems gets FDA nod to expand bacteria panel

By LabPulse.com staff writers

T2 Biosystems announced it received 510(k) clearance to add A. baumannii to its T2Bacteria Panel.

February 12, 2024

Fda Button Social

CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

By LabPulse.com staff writers

CARB-X will award up to $1.8 million to biotech firm Visby Medical to develop a portable rapid polymerase chain reaction test to detect Neisseria gonorrhoeae, the pathogen that causes gonorrhea, including its susceptibility to ciprofloxacin.

February 8, 2024

Bacteria Neisseria Gonorrhoeae Social

High hopes for accurate blood test detecting malignant brain tumors

A simple blood test to detect malignant brain tumors that can be hard to locate could spare many cancer patients risky and invasive surgery, say scientists.

February 9, 2024

Blood Test Samples Lab Social

U.K. trial for mRNA-based cancer therapy begins

Cancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.

February 7, 2024

Messenger Rna M Rna Social

NHS launches Jewish BRCA mutations testing program

By LabPulse.com staff writers

The U.K. National Health Service (NHS) is launching a national genetic testing program aimed at people in England with Jewish ancestry who may be carriers of mutations in BRCA1 and BRCA2 genes that increase their risk of certain cancers.

February 5, 2024

Dna Genome Gene Targeted Social

Cytokine improves outcomes in mice with sepsis, predicts survival in humans

By Nick Paul Taylor

Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.

February 6, 2024

Antigen Tcell Cytokines Social

CRISPR-repaired T cells cure lethal hyperinflammation in mice

By Nick Paul Taylor

Memory T cells repaired using CRISPR-Cas9 can cure lethal hyperinflammation in mice, suggesting the approach may improve outcomes in a disease with a five-year probability of survival of around 50%.

February 2, 2024

Page 5 of 284